Emergent Fundamentals

EBS
 Stock
  

USD 11.90  0.15  1.24%   

Emergent Biosolutions fundamentals help investors to digest information that contributes to Emergent Biosolutions' financial success or failures. It also enables traders to predict the movement of Emergent Stock. The fundamental analysis module provides a way to measure Emergent Biosolutions' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emergent Biosolutions stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Emergent Biosolutions Operating Income is relatively stable at the moment as compared to the past year. Emergent Biosolutions reported last year Operating Income of 352.6 Million. As of 11/27/2022, Revenues is likely to grow to about 1.9 B, while Interest Expense is likely to drop slightly above 27.4 M.

Emergent Revenue Analysis

Emergent Biosolutions' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Emergent Biosolutions Revenues

1.93 Billion

Revenue 
 = 
Money Received 
Discounts and Returns 
More About Revenue | All Equity Analysis

Current Emergent Biosolutions Revenue

    
  1.6 B  
Most of Emergent Biosolutions' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emergent Biosolutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Emergent Revenue Historical Pattern

Today, most investors in Emergent Biosolutions Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Emergent Biosolutions' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Emergent Biosolutions revenue as a starting point in their analysis.
   Emergent Biosolutions Revenue   
Share
       Timeline  
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition

Emergent Deferred Revenue

Deferred Revenue

37.84 Million

Emergent Biosolutions Deferred Revenue is relatively stable at the moment as compared to the past year. Emergent Biosolutions reported last year Deferred Revenue of 35.08 Million
Based on the latest financial disclosure, Emergent Biosolutions reported 1.6 B of revenue. This is 79.02% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The revenue for all United States stocks is 83.04% higher than that of the company.

Emergent Biosolutions Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Emergent Biosolutions's current stock value. Our valuation model uses many indicators to compare Emergent Biosolutions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Emergent Biosolutions competition to find correlations between indicators driving Emergent Biosolutions's intrinsic value. More Info.
Emergent Biosolutions is one of the top stocks in operating margin category among related companies. It is one of the top stocks in working capital category among related companies reporting about  31,655,748  of Working Capital per Operating Margin. Emergent Biosolutions Operating Margin is relatively stable at the moment as compared to the past year. Emergent Biosolutions reported last year Operating Margin of 19.67. Comparative valuation analysis is a catch-all model that can be used if you cannot value Emergent Biosolutions by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emergent Biosolutions' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Emergent Biosolutions' earnings, one of the primary drivers of an investment's value.

Emergent Biosolutions Current Valuation Drivers

We derive many important indicators used in calculating different scores of Emergent Biosolutions from analyzing Emergent Biosolutions' financial statements. These drivers represent accounts that assess Emergent Biosolutions' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Emergent Biosolutions' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee65.76 K36.77 K29.72 K434.67 K95.57 K83.02 K
Revenue Per Employee446.56 K458.89 K603.05 K2.22 M742.01 K633.64 K
Average Assets1 B1.4 B2.28 B2.56 B2.91 B2.3 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA155.67 M152.7 M224 M548.4 M469.6 M506.67 M
Earnings Before Interest Taxes and Depreciation Amortization USD167.8 M153.6 M226.5 M553 M472.7 M510.02 M
Earnings before Tax118.6 M81.5 M77.4 M407.2 M314.4 M339.22 M
Average Equity701.76 M949.29 M1.02 B1.24 B1.55 B1.26 B
Enterprise Value1.83 B2.69 B3.47 B5.21 B2.78 B2.6 B
Free Cash Flow153.3 M(30.3 M)101.1 M395 M96.1 M91.2 M
Invested Capital635.6 M1.69 B1.77 B1.82 B2.02 B1.67 B
Invested Capital Average742.21 M911.65 M1.67 B1.77 B2.01 B1.61 B
Market Capitalization1.92 B3.02 B2.79 B4.75 B2.34 B2.32 B
Tangible Asset Value901.5 M1.21 B1.35 B1.95 B2.13 B1.75 B
Working Capital385.3 M420.4 M469.9 M811.4 M898.3 M723.74 M

Emergent Fundamentals

About Emergent Biosolutions Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Emergent Biosolutions's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emergent Biosolutions using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emergent Biosolutions based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Deferred Revenue35.1 M37.8 M
Cost of Revenue757.5 M817.3 M
Revenues1.8 B1.9 B
Revenue to Assets 0.61  0.61 
Revenue Per Employee742 K633.6 K

Emergent Biosolutions Investors Sentiment

The influence of Emergent Biosolutions' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Emergent. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Emergent Biosolutions' public news can be used to forecast risks associated with investment in Emergent. The trend in average sentiment can be used to explain how an investor holding Emergent can time the market purely based on public headlines and social activities around Emergent Biosolutions. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Emergent Biosolutions' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Emergent Biosolutions' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Emergent Biosolutions' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Emergent Biosolutions.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Emergent Biosolutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Emergent Biosolutions' short interest history, or implied volatility extrapolated from Emergent Biosolutions options trading.

Pair Trading with Emergent Biosolutions

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emergent Biosolutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will appreciate offsetting losses from the drop in the long position's value.

Moving against Emergent Biosolutions

-0.7TWTRTwitter DelistingPairCorr
-0.68MRNAModerna Potential GrowthPairCorr
The ability to find closely correlated positions to Emergent Biosolutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emergent Biosolutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emergent Biosolutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emergent Biosolutions to buy it.
The correlation of Emergent Biosolutions is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emergent Biosolutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emergent Biosolutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emergent Biosolutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Emergent Biosolutions Piotroski F Score and Emergent Biosolutions Altman Z Score analysis. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.022
Market Capitalization
593.7 M
Quarterly Revenue Growth YOY
(0.27) 
Return On Assets
0.0464
Return On Equity
0.036
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine Emergent Biosolutions value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.